Cell Therapy Ltd. Grants Japan License To Daiichi Sankyo For Its Heart Regeneration Medicine, Heartcel™
Cell Therapy Ltd. (CTL) today announced the granting of the Japan license for its innovative cardiac regeneration medicine, Heartcel™ (immuno-modulatory progenitor [iMP] cells) to Daiichi Sankyo. Daiichi Sankyo will undertake all development, regulatory and commercial activities for iMP cells in the territory of Japan only, while CTL retains its worldwide rights outside of Japan as well as global manufacturing responsibilities. Under the terms of the agreement, CTL receives a £12.5 million upfront licensing fee and additional milestone payments and royalties.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160509006435/en/
"After a competitive process, we are delighted to partner with Daiichi Sankyo in Japan. The accelerated regulatory pathway for regenerative medicines in Japan enables faster patient access, making it a natural priority for us," said Ajan Reginald, Chief Executive Officer, CTL. "This allows CTL to focus on U.S. and European Phase 3 trials and accelerating the development of our pre-clinical pipeline."
“CTL’s in-house technology focuses on the discovery of novel tissue-specific cellular medicines. We are delighted that Daiichi Sankyo share our belief in iMP cells’ potential in heart regeneration,” commented Professor Sir Martin Evans, Nobel Laureate and CTL’s Chief Scientific Officer. “This partnership is a validation of Cell Therapy’s novel approach and discovery technology.”
iMP cells are an advanced therapeutic medicinal product (ATMP) and investigational allogeneic regenerative medicine.1 Heart failure affects approximately 26 million people worldwide. The condition features a progressive degenerative scarring of the heart associated with significant mortality and morbidity.2 iMP cells were injected into the cardiac scar during bypass surgery in a Phase 2 clinical trial of 11 severe heart failure patients at high risk of incomplete re-vascularisation (ICR).1 At 12 months following treatment, results demonstrated the following change from baseline: a 30% improvement in heart function (left ventricular ejection fraction), a 40% decrease in cardiac scar area and significant improvement in quality of life (characterised by a 50% increase in ‘Minnesota Living with Heart Failure’ score).1,3 At 36 months following treatment, all patients remained alive.1,3
About Cell Therapy Ltd.
Cell Therapy Limited (CTL) is a private British regenerative medicine company that has discovered and developed a pipeline of novel cellular medicines in areas of high unmet clinical need. CTL was founded in 2009 by Nobel Laureate Professor Sir Martin Evans and former Roche Global Head of Emerging Technologies Ajan Reginald. CTL’s disruptive technology platform drives in-house discovery and manufacture of a pipeline of novel tissue-specific regenerative medicines. CTL is currently in the process of re-branding under the name Celixir.
About Heartcel TM
HeartcelTM consists of immuno-modulatory progenitor (iMP) cells, a cardiac-specific cellular medicine which has successfully completed European Phase 2 trials. Phase 3 trials are set to begin in 2016.
This Cell Therapy Ltd. press release contains "forward-looking statements" referring to the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. The statements included within this press release are based on current expectations about future beliefs and the reader is cautioned not to rely on these forward-looking statements. Cell Therapy Ltd. makes no guarantee in regards to the regulatory future of iMP cells and whether it will gain regulatory approval or achieve commercial success. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Cell Therapy Ltd. Risks and uncertainties include, but are not limited to: challenges inherent in new product development, including obtaining regulatory approvals; competition, including technological advances, new products and patents attained by competitors; challenges to patents; changes in behavior and spending patterns or financial distress of purchasers of health care products and services; changes to regulations and domestic and foreign health care reforms; and general industry conditions, including trends toward health care cost containment.
The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.
1. Data presented at the International Society of Stem Cell Research (ISSCR) Annual Conference in Stockholm, 24th June, 2015. Available at: http://tinyurl.com/jldmygy.
2. Heart failure: Preventing disease and death worldwide. European Society of Cardiology, 2014. Available at: https://www.escardio.org/static_file/Escardio/Subspecialty/HFA/WHFA-whitepaper-15-May-14.pdf.
3. Data presented at the European Society of Gene and Cell Therapy Annual Congress in Helsinki, 18th September, 2015. Available at: http://tinyurl.com/hbjdqu9.
+44 (0) 207 072 4216
+44 (0) 791 025 7455
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Theorem Solutions: Democratising Augmented, Mixed and Virtual Reality24.10.2017 10:00 | Pressemelding
Theorem Solutions of Tamworth, UK, have launched a ‘Multi-Device’ Visualization Experience App for Augmented (AR), Mixed (MR) and Virtual Reality (VR) devices and markets. The Visualization Experience app forms part of Theorem’s ‘Digital Realities’ product family, and has been specifically developed for users to engage and interact with their Engineering and Manufacturing data. It is one of the first to offer a single solution for all three different technologies in a single application. Supported devices are: Augmented Reality - Windows 10 and Android Tablets and Phones Mixed Reality – Microsoft HoloLens Virtual Reality - HTC Vive and Oculus Rift Being Multi-Device, the application allows users to use the same data, in the same visualization application, on ALL of the different
Sigma Systems CTO Catherine Michel to Speak at Women in Communications Event24.10.2017 09:00 | Pressemelding
Sigma Systems, the global leader in catalog-driven software, has confirmed today that its Chief Technology Officer, Catherine Michel, will be speaking at Light Reading’s Women in Comms luncheon to be held November 1st in London. The event will take place during Light Reading’s OSS in the Era of SDN and NFV conference. Speakers include the editors of Light Reading and analysts of Heavy Reading, alongside industry guest speakers including Sigma’s Catherine Michel. This event brings together leading women in communications and their male allies to discuss everything related to the state of the industry today, including why diversity in the workplace matters, and why companies should care about the disparity in representation and pay of female employees. Earlier this year, Catherine was named to the top 50 Women to Watch 2017 and the Power 100 by Global Telecoms Business - the o
GSMA Mobile IoT Initiative Helping Operators Target European Connected Energy Market Worth USD$26 Billion24.10.2017 08:00 | Pressemelding
The GSMA today announced that mobile operators deploying new Mobile IoT networks will be able to benefit from the European connected energy market estimated to be worth USD$26 billion by 20261. Data shared by analyst house Machina Research highlights the huge growth opportunity in the emerging connected energy market that could connect approximately 158 million new smart meters on LPWA networks across Europe. The total number of connections in Europe could be further increased if the 60 million cellular connections are also included with LPWA. “The Internet of Things is fundamentally disrupting the smart utility market by providing ubiquitous connectivity and real-time, actionable data. Mobile IoT networks will take this further by offering energy providers a cost-effective solution to connect millions of smart meters,” said Alex Sinclair, Chief Technology Officer, GSMA. “There is a
RevolutionAir: Philips Launches a Brand-New Wireless SpeechMike Premium Air24.10.2017 07:02 | Pressemelding
Speech Processing Solutions, the world’s number one in professional dictation, has just released its latest innovation, the wireless SpeechMike Premium Air dictation microphone. For the first time in history, the new device offers not only outstanding audio recording quality, enabling exceptional speech recognition results, best in class quality and ergonomics, but also a wireless dictation microphone, based on 100% lossless speech technology. The dictation microphone allows users to quickly turn their voice into text, saving them time and making them more effective at their core profession. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171024005093/en/ Philips SpeechMike Premium Air (Photo: Business Wire) Lossless speech technology The high-quality device deliver
Philip Morris International Recognized for Environmental Leadership on CDP’s A List for Climate and Water24.10.2017 07:00 | Pressemelding
Philip Morris International Inc. (“PMI”) (NYSE/Euronext Paris: PM) today was again recognized as a global leader for environmental action in the annual CDP rankings. For the fourth year in a row, PMI is on the CDP Climate A List for taking comprehensive action on climate change and for its transparent disclosure process. In addition, PMI achieved A List status for CDP Water, recognizing the company’s water stewardship initiatives. PMI is one of only 25 companies that scored an A for both climate and water, placing the company in the top 1% of corporations known as the “A Listers” for both schemes. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171024005711/en/ CDP, formerly known as the Carbon Disclosure Project, is the leading international not-for-profit organization independently assessing the environmental efforts of t
QVC Makes the Leap into Ultra HD in Germany with SES Video24.10.2017 06:50 | Pressemelding
QVC will bring an enhanced TV experience to its viewers with the launch of its Ultra HD channel in Germany, the seventh channel in ultra-high definition in the country, via SES’s prime orbital slot 19.2 degrees East. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171023005870/en/ QVC Makes the Leap into Ultra HD in Germany with SES Video (Photo: Business Wire) Under the ten-year agreement announced by SES, QVC will utilize additional capacity for its upgrade to Ultra HD and rely on SES’s wholly-owned subsidiary MX1 for encoding in HEVC format and uplink services. QVC is also renewing capacity for distribution of the channel in Standard and High Definition. “As we carry the largest line-up of HD and UHD channels worldwide, it is part of our DNA to help our customers bring the best pos
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom